Migration of Intraureteral Stents Compared to Conventional Double-J Stents.
NCT04763837 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2022-04-29
Summary
The purpose of this study is to determine if stents placed with only one loop in the kidney move more than stents placed with a loop in both the kidney and a bladder. Participants in this study will undergo placement of a stent into the ureter that drains urine from the kidney into the bladder. The stent will be placed in 1 of 2 ways: either with only a loop of the stent is left in the kidney or in the regular manner where a loop of the stent is left in both the kidney and in the bladder. The position of the stent will be measured at the time of placement. When the stent is removed, the position of the stent will be measured prior to pulling the stent.
Conditions
- Urologic Diseases
- Urological System Complication of Procedure
Interventions
- DEVICE
-
Intraureteral stent
This intervention involves the placement of an intraureteral stent, a tube that drains urine from the kidney to the bladder and has a loop of tube only in the kidney and NOT in the bladder. The distal end of the tube will stay in the ureter just proximal to the opening to the bladder.
- DEVICE
-
Conventional Double-J stent
This intervention involves the placement of a conventional double-J stent, a tube that drains urine from the kidney to the bladder and has a loop of tube in both the kidney and in the bladder.
Sponsors & Collaborators
-
University of Louisville
lead OTHER
Principal Investigators
-
Kellen B Choi, DO, FACOS · Associate Professor, University of Louisville Department of Urology
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 1 Year
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2027-02-28
- Primary Completion
- 2028-04-30
- Completion
- 2028-04-30
- FDA Device
- Yes
More Related Trials
-
Assessment of Drug-eluting Ureteral Stent on Bacterial Adherence and Biofilm Formation
NCT00250406 ·Status: COMPLETED ·Phase: PHASE2
-
Intravascular Stents Fracture Effects
NCT01382381 ·Status: UNKNOWN
-
Endurant Bifurcated and Aorto-Uni-Iliac (AUI) Stent Graft System
NCT00705718 ·Status: COMPLETED ·Phase: NA
-
MGuard™ Prime Stent System Clinical Trial in Patients With Acute ST Elevation Myocardial Infarction
NCT01869738 ·Status: TERMINATED ·Phase: NA
-
MicroNet-covered Stent System for Stroke Prevention in All Comer Carotid Revascularization
NCT04271033 ·Status: RECRUITING ·Phase: NA
-
High Coverage CARotid Stenting vs. Medical Management Alone to Prevent EmboliSm From symptomaTic Non-stenotic cARotid Disease (SyNC)
NCT07166731 ·Status: RECRUITING
-
The Complete® Self-Expanding Stent and Stent Delivery System Registry
NCT00730730 ·Status: COMPLETED ·Phase: NA
-
The STAPLE International Post-Market Registry
NCT01276249 ·Status: TERMINATED
-
Randomised Trial of Dual Device Treatment Involving Drug-coated Balloon Angioplasty and Drug-eluting Stent Implantation Compared to Single Device Treatments in Patients With Diabetes Mellitus
NCT07303439 ·Status: RECRUITING ·Phase: NA
-
Reduction of Stent Associated Morbidity by Minimizing Stent Material.
NCT03217318 ·Status: COMPLETED ·Phase: NA
-
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft Investigational Device Exemption (IDE) Study
NCT02949297 ·Status: COMPLETED ·Phase: NA
-
Medical & Economical Evaluation of Fenestrated & Branched Stent-grafts to Treat Complex Aortic Aneurysms
NCT01168037 ·Status: COMPLETED
-
Safety and Effectiveness Study of the HERCULINK 14 Stent to Treat Renal Artery Disease
NCT00180544 ·Status: TERMINATED ·Phase: PHASE3
-
A Single-arm, Pivotal Study to Evaluate Acute Device and Technical Success of the CGuard Prime Carotid Stent System When Used in Conjunction to the ENROUTE Transcarotid Neuroprotection System in Patients Undergoing Carotid Artery Stenting Via the Transcarotid Artery Revascularization Approach
NCT06653387 ·Status: RECRUITING ·Phase: NA
-
RESOLUTE ONYX Post-Approval Study (Bifurcation Cohort)
NCT03584464 ·Status: COMPLETED ·Phase: NA
-
Benefits of Medical Therapy Plus Stenting for Renal Atherosclerotic Lesions
NCT00081731 ·Status: COMPLETED ·Phase: PHASE3
-
Early Feasibility Study of the RelayBranch Thoracic Stent-Graft System
NCT03214601 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
NCT05378347 ·Status: RECRUITING ·Phase: NA
-
Safety and Efficacy of the CGuard™ Carotid Stent System in Carotid Artery Stenting
NCT04900844 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
OPTIMAl Endovascular Exclusion of Consecutive Patient High-risk Carotid Plaque Using the MicroNet Covered Stent
NCT04234854 ·Status: UNKNOWN
-
Catheter-Based Treatment of Cardiovascular Disease
NCT00380016 ·Status: COMPLETED ·Phase: NA
-
Aorto-iliac Occlusion Treatment With ShorT Unibody aorTic Endograft - ASTUTE Study
NCT05614856 ·Status: SUSPENDED
-
Tritanium® Primary Acetabular Shell Study
NCT01063751 ·Status: TERMINATED ·Phase: NA
-
Talent Aortic Cuff Stent Graft System Compassionate Use Registry
NCT00604643 ·Status: NO_LONGER_AVAILABLE
-
CONTINuous Infra-Inguinal Stenting Using the Bard® LifeStent® VascUlar Stent SysteMs ("CONTINUUM")
NCT00908947 ·Status: TERMINATED ·Phase: NA